• Sorry! To unlock all site features, we'll need to collect some information from you.
  • Unit 7.2: Platelet Glycoprotein (GP) IIb/IIIa Inhibitors

    David Moliterno, MD — University of Kentucky

    Duration:1 hour

    Faculty Disclosure

    Nothing to Disclose

    Learning Objectives

    • Describe the function and action of the platelet glycoprotein (GP) IIb/IIIa receptor
    • List features and characteristics that distinguish the three commercially available GP IIb/IIIa antagonists
    • Summarize the relative risk reductions in ischemic events (death and myocardial infarction) provided by GP IIb/IIIa inhibitors in ACS and PCI
    • List major complications with IIb/IIIa inhibitors and the percent of patients experiencing adverse events
    • Describe measures used to minimize complications associated with GP IIb/IIIa inhibitors